Azelby Robert (CIK 1656998) reported 6 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-23). Recent activity: Buy TNGX (5,740 shares), Buy ADCT (45,000 shares), Sell ADCT (12,600 shares), Buy CAH (1,067 shares), Sell ADCT (12,600 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-23 | Tango Therapeutics, Inc. (TNGX) | Director | Buy | 5,740 | $0 |
| 2026-06-03 | ADC Therapeutics SA (ADCT) | Director | Buy | 45,000 | $0 |
| 2026-06-03 | ADC Therapeutics SA (ADCT) | Director | Sell | 12,600 | $38,808 |
| 2025-11-06 | CARDINAL HEALTH INC (CAH) | Director | Buy | 1,067 | $0 |
| 2025-06-17 | ADC Therapeutics SA (ADCT) | Director | Sell | 12,600 | $45,108 |
| 2025-06-05 | ADC Therapeutics SA (ADCT) | Director | Buy | 40,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-23